Two Sigma Advisers’s Amgen AMGN Stock Holding History

Two Sigma Advisers’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-735,880	Closed	-$241M	–	107
2025 Q4	$241M	Buy	735,880 +674,680	+1,102%	+$214M	0.47%	48
2025 Q3	$17.3M	Buy	61,200 +57,100	+1,393%	+$16.6M	0.03%	362
2025 Q2	$1.14M	Sell	4,100 -997,300	-100%	-$283M	﹤0.01%	1373
2025 Q1	$312M	Sell	1,001,400 -544,200	-35%	-$161M	0.7%	32
2024 Q4	$403M	Buy	1,545,600 +760,700	+97%	+$226M	0.93%	23
2024 Q3	$253M	Buy	784,900 +68,000	+9%	+$22.2M	0.59%	45
2024 Q2	$224M	Buy	716,900 +367,200	+105%	+$108M	0.5%	44
2024 Q1	$99.4M	Sell	349,700 -809,000	-70%	-$237M	0.23%	94
2023 Q4	$334M	Sell	1,158,700 -297,400	-20%	-$81M	0.78%	19
2023 Q3	$391M	Sell	1,456,100 -146,800	-9%	-$36.6M	1%	13
2023 Q2	$356M	Sell	1,602,900 -69,900	-4%	-$16.2M	0.91%	16
2023 Q1	$404M	Buy	1,672,800 +135,400	+9%	+$33.2M	1.04%	13
2022 Q4	$404M	Sell	1,537,400 -146,100	-9%	-$39.2M	1.13%	12
2022 Q3	$379M	Buy	1,683,500 +21,800	+1%	+$5.28M	1.1%	13
2022 Q2	$404M	Sell	1,661,700 -68,800	-4%	-$16.9M	1.15%	6
2022 Q1	$418M	Sell	1,730,500 -77,900	-4%	-$17.9M	1.11%	10
2021 Q4	$407M	Sell	1,808,400 -44,000	-2%	-$9.29M	1.02%	12
2021 Q3	$394M	Buy	1,852,400 +572,000	+45%	+$132M	1.02%	12
2021 Q2	$312M	Buy	1,280,400 +1,238,900	+2,985%	+$305M	0.82%	19
2021 Q1	$10.3M	Buy	41,500 +33,800	+439%	+$8.06M	0.03%	563
2020 Q4	$1.77M	Buy	7,700 +2,685	+54%	+$619K	﹤0.01%	1321
2020 Q3	$1.27M	Sell	5,015 -242,636	-98%	-$60.1M	﹤0.01%	1389
2020 Q2	$58.4M	Buy	247,651 +19,500	+9%	+$4.45M	0.17%	131
2020 Q1	$46.3M	Sell	228,151 -308,045	-57%	-$67.3M	0.18%	130
2019 Q4	$129M	Sell	536,196 -477,200	-47%	-$105M	0.3%	81
2019 Q3	$196M	Sell	1,013,396 -1,651,200	-62%	-$317M	0.48%	46
2019 Q2	$491M	Buy	2,664,596 +415,300	+18%	+$74.4M	1.22%	3
2019 Q1	$427M	Buy	2,249,296 +180,000	+9%	+$34.4M	1.08%	1
2018 Q4	$403M	Buy	2,069,296 +315,600	+18%	+$61.6M	1.1%	1
2018 Q3	$364M	Buy	1,753,696 +182,100	+12%	+$35.9M	0.89%	7
2018 Q2	$290M	Buy	1,571,596 +780,100	+99%	+$138M	0.78%	8
2018 Q1	$135M	Sell	791,496 -1,507,700	-66%	-$277M	0.37%	57
2017 Q4	$400M	Buy	2,299,196 +130,500	+6%	+$23.1M	1.08%	1
2017 Q3	$404M	Buy	2,168,696 +14,900	+0.7%	+$2.64M	1.15%	2
2017 Q2	$371M	Buy	2,153,796 +1,666,097	+342%	+$271M	1.22%	2
2017 Q1	$80M	Sell	487,699 -710,712	-59%	-$118M	0.26%	97
2016 Q4	$175M	Buy	1,198,411 +986,670	+466%	+$148M	0.67%	15
2016 Q3	$35.3M	Sell	211,741 -172,963	-45%	-$29.2M	0.15%	158
2016 Q2	$58.5M	Sell	384,704 -31,200	-8%	-$4.85M	0.3%	84
2016 Q1	$62.4M	Buy	415,904 +256,703	+161%	+$38.1M	0.35%	75
2015 Q4	$25.8M	Sell	159,201 -775,969	-83%	-$122M	0.15%	165
2015 Q3	$130M	Buy	935,170 +61,123	+7%	+$9.63M	0.82%	13
2015 Q2	$134M	Buy	874,047 +166,458	+24%	+$26.7M	1%	3
2015 Q1	$113M	Buy	707,589 +682,000	+2,665%	+$107M	0.83%	9
2014 Q4	$4.08M	Sell	25,589 -3,276	-11%	-$510K	0.03%	546
2014 Q3	$4.05M	Sell	28,865 -665,200	-96%	-$86.8M	0.03%	563
2014 Q2	$82.2M	Buy	+694,065	New	+$80.3M	0.64%	16
2014 Q1	–	Sell	-40,065	Closed	-$4.86M	–	2236
2013 Q4	$4.57M	Buy	+40,065	New	+$4.56M	0.04%	410

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Two Sigma Advisers's AMGN Position: Q1 2026 in Review

Two Sigma Advisers sold out of Amgen (AMGN) in Q1 2026, closing a stake of 735,880 shares — an estimated $241M sold.

Two Sigma Advisers first reported a position in AMGN in Q4 2013 and held it in 48 quarters. The position peaked at $491M in Q2 2019. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Two Sigma Advisers reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 735,880 Amgen shares in Q1 2026, an estimated $241M.
Two Sigma Advisers first reported a position in Amgen in Q4 2013 and held it in 48 quarters.
Two Sigma Advisers's Amgen position peaked at $491M in Q2 2019.
3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.